Article info

Download PDFPDF

Original research
First in human dose calculation of a single-chain bispecific antibody targeting glioma using the MABEL approach

Authors

  • Teilo H Schaller Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina, United States Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina, United States Department of Pathology, Duke University Medical Center, Durham, North Carolina, United States PubMed articlesGoogle scholar articles
  • David J Snyder Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina, United States Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina, United States PubMed articlesGoogle scholar articles
  • Ivan Spasojevic PK/PD Core Laboratory, Duke Cancer Institute, Durham, North Carolina, United States Department of Medicine, Duke University School of Medicine, Durham, North Carolina, United States PubMed articlesGoogle scholar articles
  • Patrick C Gedeon Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina, United States Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina, United States PubMed articlesGoogle scholar articles
  • Luis Sanchez-Perez Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina, United States Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina, United States PubMed articlesGoogle scholar articles
  • John H Sampson Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina, United States Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina, United States Department of Pathology, Duke University Medical Center, Durham, North Carolina, United States PubMed articlesGoogle scholar articles
  1. Correspondence to Professor John H Sampson; john.sampson{at}duke.edu
View Full Text

Citation

Schaller TH, Snyder DJ, Spasojevic I, et al
First in human dose calculation of a single-chain bispecific antibody targeting glioma using the MABEL approach

Publication history

  • Accepted March 21, 2020
  • First published April 8, 2020.
Online issue publication 
January 11, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.